Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications.
8539 Background: Interferon α-2b (IFN) is the only approved adjuvant therapy for high-risk melanoma. IFN-related cognitive deficiencies and mood alterations have been reported. Antidepressants are ...